Multiple resistance modulators combined with carboplatin for resistant malignancies: A pilot study David J. StewartRakesh GoelShailendra Verma OriginalPaper Pages: 267 - 277
Il-4r expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4) Jie CaiTong ZhengParkash S. Gill OriginalPaper Pages: 279 - 287
An in vitro assessment of the antineoplastic potential of 2H-1,3-Oxazine-2,6(3H)-dione (3-oxauracil), a novel pyrimidine Lawton SealDaniel Von HoffRichard M. Jamison OriginalPaper Pages: 289 - 293
Preclinical toxicity of a new oral anticancer drug, CI-994 (Acetyldinaline), in rats and dogs Michael J. GrazianoGaryD. PilcherLouis Radulovic OriginalPaper Pages: 295 - 310
Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-α (PKC-α) pseudosubstrate peptides through a P-glycoprotein-independent mechanism Philip J. BergmanKaren R. GravittCatherine A. O'Brian OriginalPaper Pages: 311 - 318
An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92 Joan H. SchillerDonna NeubergJanice Dutcher OriginalPaper Pages: 319 - 324
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies John D. HainsworthSusan M. UtleyF. Anthony Greco OriginalPaper Pages: 325 - 329
A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors Randall BrandMary CapadanoMargaret Tempero OriginalPaper Pages: 331 - 341
A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma William J. BergLawrence H. SchwartzRobert J. Motzer OriginalPaper Pages: 353 - 355
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241) John S. MacdonaldJacqueline K. BenedettiDavid S. Alberts OriginalPaper Pages: 357 - 359
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer Jivesh J. SharmaBetty RazvillasMace L. Rothenberg OriginalPaper Pages: 361 - 364